Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × toripalimab × 90 days × Clear all

Phase

Status

Sponsor Class

OTHER 36 INDUSTRY 16 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Breast Cancer 1

Interventions

Bevacizumab 5 Radiotherapy 4 Capecitabine 4 Radiosurgery 3 Oxaliplatin 3 pembrolizumab 2 durvalumab 2 atezolizumab 2 anlotinib 2 Olanzapine 2 Hyperthermic Intraperitoneal Chemotherapy 2 Dexamethasone 2 Cisplatin 2 trilaciclib 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 spartalizumab 1 pyrotinib 1 pomalidomide 1 pegfilgrastim 1 olaparib 1 ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 irinotecan sucrosofate 1 hetrombopag 1 fosaprepitant 1 ferric maltol 1 defactinib 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡